SAN DIEGO, July 27, 2010 (GLOBE NEWSWIRE) -- Entest BioMedical Inc. (OTCBB:ENTB) today announced that it has retained Crescendo Communications, LLC (“Crescendo”) as its investor relations firm to help broaden awareness of the company within the financial markets.
